CSX vs PRME · P/E 19, rev $7.42B vs rev $3.0M
CSX Corporation (CSX) versus Prime Medicine, Inc. Common Stock (PRME) — a side-by-side from cached financials, not a winner call.
CSX Corporation (CSX) is a railroads company listed on US.
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
Latest reported CSX revenue for 2026-06-30 was $7.42B. Net income was $1.81B. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
Latest reported PRME revenue for 2024-12-31 was $3.0M. Net income was -$195.9M. PRME currently screens at market cap $570.8M.
CSX currently screens at market cap $61.18B and trailing P/E 19.4. PRME currently screens at market cap $570.8M.
Not investment advice. Open the CSX and PRME stock pages for the full models.
Not investment advice.